Acadia Pharmaceuticals | ACAD - EPS Earnings Per Share


Acadia Pharmaceuticals reported $0.02 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.13 0.42 Nov/11
FY2026Q2 Jun/2026 0.06 0.16 Aug/04
FY2026Q1 Mar/2026 0.02 0.07 0.11 May/06
FY2025Q4 Dec/2025 1.60 0.14 0.86 Feb/25
FY2025Q3 Sep/2025 0.42 0.14 0.20 Nov/05




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
ALKERMES USD 0 0.4 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Cara Therapeutics USD -0.72 0.14 Mar/2026
Corcept Therapeutics USD 0.36 0.66 Jun/2026
Cytokinetics USD -1.67 0.17 Mar/2026
Eisai JPY 64.71 76.24 Jun/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Incyte USD 3.09 1.28 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Moderna USD -1.97 1.43 Jun/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Prothena USD 0.6 1.06 Mar/2026
PTC Therapeutics USD 0.92 0.95 Jun/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026